This work is licensed under the Creative Commons Attribution 4.0 International License.
Vijzelaar R, Botton MR, Stolk L, Martis S, Desnick RJ, Scott SA. Multi-ethnic SULT1A1 copy number profiling with multiplex ligation-dependent probe amplification. Pharmacogenomics. 2018; 19:761–70.VijzelaarRBottonMRStolkLMartisSDesnickRJScottSAMulti-ethnic SULT1A1 copy number profiling with multiplex ligation-dependent probe amplification20181976170Search in Google Scholar
Martis S, Mei H, Vijzelaar R, Edelmann L, Desnick RJ, Scott SA. Multi-ethnic cytochrome-P450 copy number profiling: novel pharmacogenetic alleles and mechanism of copy number variation formation. Pharmacogenomics. 2013; 13:558–66.MartisSMeiHVijzelaarREdelmannLDesnickRJScottSAMulti-ethnic cytochrome-P450 copy number profiling: novel pharmacogenetic alleles and mechanism of copy number variation formation20131355866Search in Google Scholar
Gaedigk A, Twist GP, Leeder JS. CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR. Pharmacogenomics. 2012; 13:91–111.GaedigkATwistGPLeederJSCYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR20121391111Search in Google Scholar
Santos M, Niemi M, Hiratsuka M, Kumondai M, Ingelman-Sundberg M, Lauschke VM, Rodríguez-Antona C. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics. Genet Med. 2018; 20:622–9.SantosMNiemiMHiratsukaMKumondaiMIngelman-SundbergMLauschkeVMRodríguez-AntonaCNovel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics2018206229Search in Google Scholar
Tremmel R, Klein K, Battke F, Fehr S, Winter S, Scheurenbrand T, et al. Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expression. Hum Genet. 2020; 139:137–49.TremmelRKleinKBattkeFFehrSWinterSScheurenbrandTCopy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expression202013913749Search in Google Scholar
Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, et al. STrengthening the reporting of OBservational studies in epidemiology – Molecular epidemiology (STROBE-ME): an extension of the STROBE statement. Eur J Clin Invest. 2012; 42:1–16.GalloVEggerMMcCormackVFarmerPBIoannidisJPKirsch-VoldersMSTrengthening the reporting of OBservational studies in epidemiology – Molecular epidemiology (STROBE-ME): an extension of the STROBE statement201242116Search in Google Scholar
Nguyen HH, Ma TTH, Vu NP, Bach QTN, Vu TH, Nguyen TD, Nong HV. Single nucleotide and structural variants of CYP2D6 gene in Kinh Vietnamese population. Medicine (Baltimore). 2019; 98:e15891. doi: 10.1097/MD.0000000000015891NguyenHHMaTTHVuNPBachQTNVuTHNguyenTDNongHVSingle nucleotide and structural variants of CYP2D6 gene in Kinh Vietnamese population201998e1589110.1097/MD.0000000000015891Open DOISearch in Google Scholar
Ahani A, Akbari MT, Saliminejad K, Behnam B, Akhondi MM, Vosoogh P, et al. Screening for large rearrangements of the RB1 gene in Iranian patients with retinoblastoma using multiplex ligation-dependent probe amplification. Mol Vis. 2013; 19: 454–62.AhaniAAkbariMTSaliminejadKBehnamBAkhondiMMVosooghPScreening for large rearrangements of the RB1 gene in Iranian patients with retinoblastoma using multiplex ligation-dependent probe amplification20131945462Search in Google Scholar
Oscarson M, McLellan RA, Gullstén H, Yue QY, Lang MA, Bernal ML, et al. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Lett. 1999; 448:105–10.OscarsonMMcLellanRAGullsténHYueQYLangMABernalMLCharacterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population199944810510Search in Google Scholar
Kwon JT, Nakajima M, Chai S, Yom YK, Kim HK, Yamazaki H, et al. Nicotine metabolism and CYP2A6 allele frequencies in Koreans. Pharmacogenetics. 2001; 11:317–23.KwonJTNakajimaMChaiSYomYKKimHKYamazakiHNicotine metabolism and CYP2A6 allele frequencies in Koreans20011131723Search in Google Scholar
Nakajima M, Kwon JT, Tanaka N, Zenta T, Yamamoto Y, Yamamoto H, et al. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin Pharmacol Ther. 2001; 69:72–8.NakajimaMKwonJTTanakaNZentaTYamamotoYYamamotoHRelationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans200169728Search in Google Scholar
Ramírez B, Niño-Orrego MJ, Cárdenas D, Ariza KE, Quintero K, Contreras Bravo NC, et al. Copy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population. BMC Med Genomics. 2019; 12:110. doi: 10.1186/s12920-019-0556-xRamírezBNiño-OrregoMJCárdenasDArizaKEQuinteroKContreras BravoNCCopy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population20191211010.1186/s12920-019-0556-xOpen DOISearch in Google Scholar
Guzey C, Spigset O. Low serum concentrations of paroxetine in CYP2D6 ultrarapid metabolizers. J Clin Psychopharmacol. 2006; 26:211–2.GuzeyCSpigsetOLow serum concentrations of paroxetine in CYP2D6 ultrarapid metabolizers2006262112Search in Google Scholar
Varsaldi F, Miglio G, Scordo MG, Dahl ML, Villa LM, Biolcati A, Lombardi G. Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients. Eur J Clin Pharmacol. 2006; 62:721–6.VarsaldiFMiglioGScordoMGDahlMLVillaLMBiolcatiALombardiGImpact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients2006627216Search in Google Scholar
Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013; 138:103–41.ZangerUMSchwabMCytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation201313810341Search in Google Scholar
Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK. A high-resolution survey of deletion polymorphism in the human genome. Nat Genet. 2006; 38:75–81.ConradDFAndrewsTDCarterNPHurlesMEPritchardJKA high-resolution survey of deletion polymorphism in the human genome2006387581Search in Google Scholar
Rodriguez-Antona C, Gomez A, Karlgren M, Sim SC, Ingelman-Sundberg M. Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment. Hum Genet. 2010; 127:1–17.Rodriguez-AntonaCGomezAKarlgrenMSimSCIngelman-SundbergMMolecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment2010127117Search in Google Scholar
Kaida Y, Inui N, Suda T, Nakamura H, Watanabe H, Chida K. The CYP2A6*4 allele is determinant of S-1 pharmacokinetics in Japanese patients with non-small-cell lung cancer. Clin Pharmacol Ther. 2008; 83:589–94.KaidaYInuiNSudaTNakamuraHWatanabeHChidaKThe CYP2A6*4 allele is determinant of S-1 pharmacokinetics in Japanese patients with non-small-cell lung cancer20088358994Search in Google Scholar
Wang H, Bian T, Liu D, Jin T, Chen Y, Lin A, Chen C. Association analysis of CYP2A6 genotypes and haplotypes with 5-fluorouracil formation from tegafur in human liver microsomes. Pharmacogenomics. 2011; 12:481–92.WangHBianTLiuDJinTChenYLinAChenCAssociation analysis of CYP2A6 genotypes and haplotypes with 5-fluorouracil formation from tegafur in human liver microsomes20111248192Search in Google Scholar
Botton MR, Lu X, Zhao G, Repnikova E, Seki Y, Gaedigk A, et al. Structural variation at the CYP2C locus: characterization of deletion and duplication alleles. Hum Mutat. 2019; 40:e37–51.BottonMRLuXZhaoGRepnikovaESekiYGaedigkAStructural variation at the CYP2C locus: characterization of deletion and duplication alleles201940e3751Search in Google Scholar